$231 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO's 17 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 35.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BBRE | Buy | JPM BETABLDRS MSCI US REITetfs | $191,086,000 | +26.2% | 2,175,631 | +52.9% | 82.66% | +6.0% |
EOCWU | ELLIOTT OPPORTUNITY II CORP | $19,600,000 | -0.6% | 2,000,000 | 0.0% | 8.48% | -16.5% | |
IMTX | IMMATICS NV | $6,075,000 | +9.0% | 697,431 | 0.0% | 2.63% | -8.4% | |
TXN | TEXAS INSTRUMENTS INC | $4,917,000 | -16.2% | 32,000 | 0.0% | 2.13% | -29.6% | |
VT | Sell | VANGUARD TOT WORLD STK ETFetfs | $2,525,000 | -21.3% | 29,585 | -6.6% | 1.09% | -33.9% |
WTTR | New | SELECT ENERGY SERVICES INC | $2,515,000 | – | 368,829 | +100.0% | 1.09% | – |
CDAK | CODIAK BIOSCIENCES INC | $2,440,000 | -54.1% | 847,108 | 0.0% | 1.06% | -61.4% | |
BOND | Buy | PIMCO ACTIVE BOND EXCHANGE-T | $1,477,000 | +5.3% | 15,502 | +12.5% | 0.64% | -11.5% |
PLXP | PLX PHARMA INC | $152,000 | -39.9% | 62,673 | 0.0% | 0.07% | -49.2% | |
AGLE | AEGLEA BIOTHERAPEUTICS INC | $124,000 | -78.1% | 245,678 | 0.0% | 0.05% | -81.4% | |
TFFP | TFF PHARMACEUTICALS INC | $125,000 | -10.1% | 22,066 | 0.0% | 0.05% | -25.0% | |
LXRX | LEXICON PHARMACEUTICALS INC | $66,000 | -12.0% | 35,714 | 0.0% | 0.03% | -25.6% | |
APEN | APOLLO ENDOSURGERY INC | $57,000 | -39.4% | 15,601 | 0.0% | 0.02% | -47.9% | |
MSFT | Sell | MICROSOFT CORP | $11,000 | -57.7% | 44 | -48.2% | 0.01% | -61.5% |
GOOG | New | ALPHABET INC | $9,000 | – | 4 | +100.0% | 0.00% | – |
POR | PORTLAND GENERAL ELECTRIC CO | $6,000 | -14.3% | 118 | 0.0% | 0.00% | -25.0% | |
PEP | New | PEPSICO INC | $1,000 | – | 6 | +100.0% | 0.00% | – |
EVTC | Exit | EVERTEC, INC. | $0 | – | -80 | -100.0% | -0.00% | – |
BX | Exit | BLACKSTONE INC | $0 | – | -633 | -100.0% | -0.04% | – |
DVN | Exit | DEVON ENERGY CORP | $0 | – | -8,334 | -100.0% | -0.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-04
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-03-05 |
13F-HR | 2024-02-28 |
SC 13G | 2024-02-14 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-04 |
3 | 2023-06-02 |
13F-HR | 2023-05-22 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-04 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.